Concepedia

Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation1

G Stark, Anne M. Dickinson, Graham Jackson, Penelope R. A. Taylor, Stephen J. Proctor, Peter G. Middleton

Transplantation · 2003 · 62 citations · 27 references

DOI

Abstract

Because sTNFRIIs can act as TNF antagonists, the association between recipient and donor TNFRII 196R allele status and acute or extensive chronic GVHD incidence, respectively, may reflect reduced circulating sTNFRII.

References

27

CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S

Harold Glucksberg, Rainer Storb, A Fefer et al. · Transplantation · 1974 · 3.7K citations

, , +19

A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

Joan M. Bathon, Richard W. Martin, Roy Fleischmann et al. · New England Journal of Medicine · 2000 · 1.8K citations · Full text

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

Rainer Storb, H. Joachim Deeg, John Whitehead et al. · New England Journal of Medicine · 1986 · 1.4K citations

Induction of apoptosis in mature T cells by tumour necrosis factor

Lixin Zheng, Galen H. Fisher, Robert E. Miller et al. · Nature · 1995 · 1.1K citations

, , +13

Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.

K M Mohler, Dauphine Torrance, Carole Smith et al. · The Journal of Immunology · 1993 · 837 citations · Full text